• Inovio launched an underwritten public offering of common stock with accompanying warrants, or pre-funded warrants in lieu of common stock.
• The deal includes a 30-day underwriter option to buy up to 15% more shares and/or accompanying warrants on the same terms.
• Piper Sandler named sole manager for the offering.
• The transaction remains subject to market conditions, with size and pricing not yet set.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-326785), on July 31, 2026, and is solely responsible for the information contained therein.